About OncoMark
OncoMark is a company based in Dublin (Ireland) founded in 2011 was acquired by Cepheid in December 2021.. OncoMark has raised $6.72 million across 5 funding rounds from investors including Cepheid, European Commission and Enterprise Ireland. OncoMark operates in a competitive market with competitors including DermTech, NeuMoDx, Biomeme, Molbio Diagnostics and OncoStem, among others.
- Headquarter Dublin, Ireland
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of OncoMark
OncoMark has successfully raised a total of $6.72M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $4.5 million completed in July 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series A — $4.5M
-
First Round
First Round
(01 Dec 2014)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2019 | Amount | Series A - OncoMark | Valuation | Irrus Investments , Halo Business Angel Network |
|
| Feb, 2017 | Amount | Seed - OncoMark | Valuation |
investors |
|
| Feb, 2016 | Amount | Grant - OncoMark | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in OncoMark
OncoMark has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Cepheid, European Commission and Enterprise Ireland. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
A platform connecting angel investors to startups in Ireland.
|
Founded Year | Domain | Location | |
|
VC firm investing in the UK and the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by OncoMark
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - OncoMark
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Oncomark Comparisons
Competitors of OncoMark
OncoMark operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DermTech, NeuMoDx, Biomeme, Molbio Diagnostics and OncoStem, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Adhesive patch biopsies for skin cancer detection are provided.
|
|
| domain | founded_year | HQ Location |
Developer of a platform for low cost molecular testing
|
|
| domain | founded_year | HQ Location |
Smartphone-based DNA detection platform is developed for diagnostics.
|
|
| domain | founded_year | HQ Location |
Point-of-care molecular platforms for infectious disease detection are developed.
|
|
| domain | founded_year | HQ Location |
Prognostic tests for cancer detection and recurrence risk are developed.
|
|
| domain | founded_year | HQ Location |
Point-of-care molecular diagnostics are enabled by Ultrafast Photonic PCR technology.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Oncomark
Frequently Asked Questions about OncoMark
When was OncoMark founded?
OncoMark was founded in 2011 and raised its 1st funding round 3 years after it was founded.
Where is OncoMark located?
OncoMark is headquartered in Dublin, Ireland.
Is OncoMark a funded company?
OncoMark is a funded company, having raised a total of $6.72M across 5 funding rounds to date. The company's 1st funding round was a Grant of $3M, raised on Dec 01, 2014.
What does OncoMark do?
OncoMark was founded in 2011 and is based in Dublin, Ireland. Tissue-based diagnostics for cancer are developed by the company within the biotechnology sector. The flagship OncoMasTR qPCR assay is utilized to assess recurrence risk in early-stage breast cancer patients through gene analysis. Additional products for melanoma, colorectal cancer, and prostate cancer are under development. Operations focus on prognostic tools for oncology applications.
Who are the top competitors of OncoMark?
OncoMark's top competitors include DermTech, Molbio Diagnostics and NeuMoDx.
Who are OncoMark's investors?
OncoMark has 7 investors. Key investors include Cepheid, European Commission, Enterprise Ireland, European Union, and Irrus Investments.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.